ProCare Welcomes Pharmac's Move To Improve Access To Asthma Inhalers And Long-Acting Contraceptives
The changes will impact funded treatments, including:
combination inhalers branded as Symbicort Turbuhaler, DuoResp Spiromax, and Vannair
long-acting contraceptives branded as Mirena, Jaydess, and Jadelle.
From next month, patients will be able to receive a three-month supply of the inhalers at once, and these, along with the long-acting contraceptives will be stocked in general practices for the first time.
This change will reduce the need for people to visit their pharmacy to pick up their prescription and mean people can learn how to use their inhalers and collect them at the same time, rather than returning for a follow-up.
Bindi Norwell, Chief Executive at ProCare sees the decision as a win for increasing accessibility to treatment and for efficiency of work in primary care.
'Reducing barriers to get timely access to treatment, especially for people managing chronic conditions like asthma means our health care professionals can help them get better health outcomes sooner.
'However, we do want to sound a warning to members of the public around the IUD insertions. As per Medical Council requirements, GPs are required to ensure that patients are informed and have time to ask questions before giving their consent to any procedure. Patients may need to book a double or triple appointment depending on the treatment chosen.
Mihi Blair, Kaiwhakahaere Hauora Māori (General Manager - Māori Health and Equity) at ProCare believes these changes will mean the support provided to patients can be done more equitably.
'For Māori, Pacific peoples, and those living in rural areas, easier access to essential treatments can make a real difference to their health. It's encouraging to see Pharmac responding to the needs of our communities.'
ProCare supports aligning medicine access with clinical guidelines and responding to how we can improve patient experience. The changes will help streamline care delivery, reduce administrative burden, and empower clinicians to provide timely, effective treatment.
'We look forward to working with our practices to implement these changes smoothly and ensure patients are informed and supported,' says Norwell.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Scoop
13 hours ago
- Scoop
Consumer And Patient Working Group To Help Pharmac Reset
Patient advocate, Dr Malcolm Mulholland, has been appointed Chair of the new Consumer and Patient Working Group that will help Pharmac reset how it works with consumers. Pharmac has committed to a 12-month reset programme to become a more outward-focussed and transparent organisation. This is in response to multiple external reviews over the last few years which sought transformational change in Pharmac. The new working group, made up of the consumer and patient community, will decide what Pharmac focuses on for the reset programme, taking a hands-on role in the delivery of the work to ensure it reflects consumers' needs, values, and perspectives. Acting Pharmac Chief Executive, Brendan Boyle, said Dr Mulholland was selected by the patient advocacy community to lead the group, and brings a lot of mana to the role. 'We are grateful that Malcolm, and the other nine members of the working group, have offered to partner with us to help us get the Pharmac reset work right.' Dr Mulholland said, 'We've waited a long time for this opportunity. The work that Pharmac does is vitally important for the health of patients and their families, and this is why getting Pharmac to work as well as it can, will be the focus of the working group.' The working group had their first meeting on Monday 21 July at the Pharmac offices in Wellington. They finalised the group's terms of reference, confirmed the approach for the reset programme, and agreed the first set of actions to focus on. The Consumer and Patient Working Group members are: Dr Malcolm Mulholland MNZM – Patient Voice Aotearoa Libby Burgess MNZM – Breast Cancer Aotearoa Coalition Tim Edmonds – Leukaemia and Blood Cancer NZ Chris Higgins – Rare Disorders NZ Francesca Holloway – Arthritis NZ Trent Lash – Heartbeats Charitable Trust Gerard Rushton – The Meningitis Foundation Rachel Smalley MNZM – The Medicine Gap Tracy Tierney – Epilepsy NZ
Scoop
13 hours ago
- Scoop
Innovation And Optimisation To Improve Medicines Access
Associate Minister of Health Associate Health Minister David Seymour has today announced more clear expectations for Pharmac to innovate and optimise to further build on expectations set last year; to deliver the medicines and medical technology that Kiwis need. 'Increasing medicines access is one of my greatest priorities. For many New Zealanders, funding for pharmaceuticals is life or death, or the difference between a life of pain and suffering or living freely,' Mr Seymour says. Since my last letter of expectations Pharmac has: Improved overall consultation Added additional consultation to the annual tender process Changed funding criteria based on public feedback, such as the decision to fund two types of oestradiol patches Appointed Natalie McMurtry as the incoming Chief Executive to cement positive change, and continue to move towards a more transparent, inclusive, and people-focused organisation Conducted, and published a report on, the Consumer Engagement Workshop to help reset the Patient-Pharmac relationship Appointed a Consumer Working Group to help reset the Patient-Pharmac relationship Funded access to 66 additional medicines using the Government's $604 million budget boost over four years which will benefit over 200,000 New Zealanders 'This is a good start. My letter of expectations for this year makes it very clear that there is still more work to be done. I expect this positive culture shift to continue,' Mr Seymour says. 'Pharmac must modernise, or it will fall behind. It needs to adopt faster, smarter processes and explore the use of AI to lift performance.' My expectations for this year are that Pharmac should: Explore how it can optimise medicines assessment and procurement processes to make them more efficient Explore ways to utilise AI to make their processes more efficient Consider the fiscal impacts to the government of funding medicines and medical devices, including costs of societal impacts of funding or not funding a medicine or medical device Be more proactive in engaging with stakeholders Look for new and additional funding opportunities for medicines and medical devices Publish measurable performance metrics and timely decisions to increase transparency Continue to involve patients early in the process and engage with them meaningfully 'We're committed to ensuring that the regulatory system for pharmaceuticals is not unreasonably holding back access. It will lead to more Kiwis being able to access the medicines they need to live a fulfilling life,' Mr Seymour says. 'I am looking forward to continuing to work with Pharmac as we continue to ensure Kiwis get timely access to medicines and medical devices.'
RNZ News
15 hours ago
- RNZ News
Associate Health Minister David Seymour warns Pharmac to modernise or risk falling behind
Photo: RNZ The Associate Health Minister says Pharmac must modernise, "or it will fall behind." David Seymour has told the agency to "innovate and optimise" to increase access to medicines and continue the "positive culture shift" that's been underway, such as exploring ways to "utilise AI". Seymour released his latest letter of expectations today, with the hope of building on his letter from last year where he told the agency it was inappropriate to keep considering the Treaty of Waitangi's place in the health sector. Since that letter of expectation, Seymour said the drug-buying agency has improved overall consultation and changed funding criteria based on public feedback. The agency had also appointed a new chief executive to "cement positive change, and continue to move towards a more transparent, inclusive, and people-focused organisation." "This is a good start. My letter of expectations for this year makes it very clear that there is still more work to be done. I expect this positive culture shift to continue," Seymour said. Now, Seymour wanted Pharmac to modernise and "adopt faster, smarter processes and explore the use of AI to lift performance." His expectations included: Seymour told the agency he wanted it to report back to him by December this year on work done to consider the broader fiscal impacts to government and regarding societal and non-health outcomes of funding medicines and medical devices. He also expected Pharmac to "renew its organisational culture and sharpen its strategic focus, ensuring it plays a more visible and constructive role across the wider health system." As part of the "continuous improvement of organisational culture", Seymour said Pharmac needed to carry on giving effect to the Cabinet Circular specifying "Needs-based Service Provision" to meet the government's expectations for how the "targeting, commissioning and design of public services should be based on the needs of all New Zealanders." Seymour said he's committed to ensuring the regulatory system for pharmaceuticals was not "unreasonably holding back access". Sign up for Ngā Pitopito Kōrero , a daily newsletter curated by our editors and delivered straight to your inbox every weekday.
